Erwinia chrysanthemi L-asparaginase: epitope mapping and production of antigenically modified enzymes

Z B Moola, M D Scawen, T Atkinson, D J Nicholls, Z B Moola, M D Scawen, T Atkinson, D J Nicholls

Abstract

This study shows that the antigenicity of Erwinia chrysanthemi L-asparaginase can be reduced by site-directed mutagenesis. Ten B-cell epitopes of the enzyme were identified using synthetic hexapeptides and polyclonal antisera from rabbits and mice. The region 282GIVPPDEELP292 near the C-terminus was an immunodominant epitope. Binding of two hexapeptides (283IVPPDE288 and 287DEELPG292) to the antibodies was dependent on Pro285, and Pro286, since their replacement by almost any other amino acid resulted in reduced binding. The other residues were less important for binding the antibodies, as binding was relatively unaffected by amino acid substitutions. Three site-directed mutant enzymes, P285T (proline-285-->threonine etc.), P286Q and E288A, were expressed in Escherichia coli. The purified enzymes had subunit M(r) values of 35,000. The pI values of P285T, P286Q and the wild-type enzymes were 8.6, and that for the mutant E288A was 9.2. The kcat. and Km values for the mutants P286Q and E288A with L-asparagine and L-glutamine were comparable with those of the wild-type enzyme. The Km values for the mutant P285T with both substrates was similar to that of the wild-type enzyme, whereas the kcat. was reduced by 2-fold with L-asparagine and by 4-fold with L-glutamine. The change proline-->threonine reduced the antigenicity of the enzyme by 8-fold, as shown in sandwich e.l.i.s.a.s. using monoclonal antibodies raised against the wild-type enzyme.

References

    1. J Gen Microbiol. 1971 Dec;69(3):299-312
    1. Gene. 1988 Aug 15;68(1):139-49
    1. Gene. 1986;46(1):25-35
    1. Cell. 1982 Mar;28(3):477-87
    1. Cancer Biochem Biophys. 1984 Jun;7(2):175-86
    1. Biochem Biophys Res Commun. 1992 Apr 15;184(1):144-8
    1. J Mol Recognit. 1988 Feb;1(1):32-41
    1. Med Pediatr Oncol. 1990;18(6):497-502
    1. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3352-6
    1. J Exp Med. 1953 Dec;98(6):583-606
    1. J Exp Med. 1963 Jul;118:99-120
    1. J Immunol Methods. 1987 Sep 24;102(2):259-74
    1. Int J Cancer. 1982 Sep 15;30(3):343-7
    1. Trends Biotechnol. 1991 May;9(5):163-9
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
    1. Gene. 1990 Jul 2;91(1):101-5
    1. Bioseparation. 1992;2(6):335-41
    1. Biochimie. 1971;53(11):1157-65
    1. J Gen Microbiol. 1986 Jan;132(1):151-60
    1. Ann N Y Acad Sci. 1990;613:95-108
    1. Med Pediatr Oncol. 1976;2(4):441-2
    1. Hoppe Seylers Z Physiol Chem. 1980;361(2):105-17
    1. Chem Immunol. 1989;46:1-22
    1. J Biol Chem. 1951 Nov;193(1):265-75
    1. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1474-8
    1. Nature. 1984 Nov 8-14;312(5990):127-34
    1. Ann Clin Biochem. 1978 Sep;15(5):270-5
    1. Nucleic Acids Res. 1985 Jun 25;13(12):4431-43
    1. Leuk Lymphoma. 1993;10 Suppl:153-7

Source: PubMed

3
Subscribe